Mice with the elevated expression of a major antioxidant selenoprotein (GPX1) showed hyperglycemia, hyperinsulinemia, elevated body fat accretion and plasma leptin and reduced insulin sensitivity. This evidence concerns the gene LEP and hyperinsulinism.